Health · 30 views
Centers for Medicare & Medicaid Services extends short-term bridge program for GLP-1 obesity drug coverage
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare, called the BALANCE model , will not launch as scheduled on Jan. 1, 2027.
AI Summary
The Centers for Medicare & Medicaid Services has made a decision regarding its temporary program for covering GLP-1 obesity drugs. The program, initially set to launch on January 1, 2027, will not proceed as planned.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Running marathons with type 1 diabetes can be safe, small study showsContinue reading
- Accelerated research, increased investment signal landmark year for food is medicineContinue reading
- A single protein may help aggressive breast cancer spread to the brain and evade immune defensesContinue reading
- Small study suggests around half of US teens witness online harm, and around a third have been targetedContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow